We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

173 hedge funds and large institutions have $1.61B invested in Cardiovascular Systems, Inc. in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 67 increasing their positions, 63 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

344% more call options, than puts

Call options by funds: $4.55M | Put options by funds: $1.02M

12% more capital invested

Capital invested by funds: $1.44B → $1.61B (+$175M)

6% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 63

1% less funds holding

Funds holding: 174173 (-1)

5% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 19

Holders
173
Holders Change
-1
Holders Change %
-0.57%
% of All Funds
3.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
67
Reduced
63
Closed
19
Calls
$4.55M
Puts
$1.02M
Net Calls
+$3.52M
Net Calls Change
+$3.98M
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
$2.6M +$1.16M +29,674 +95%
Citadel Advisors
52
Citadel Advisors
Florida
$2.52M -$1.07M -27,420 -32%
AllianceBernstein
53
AllianceBernstein
Tennessee
$2.4M +$188K +4,810 +9%
Wells Fargo
54
Wells Fargo
California
$2.36M -$553K -14,152 -20%
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$2.31M -$197K -5,031 -8%
Two Sigma Investments
56
Two Sigma Investments
New York
$2.22M -$204K -5,212 -9%
Russell Investments Group
57
Russell Investments Group
United Kingdom
$2.17M -$115K -2,932 -5%
PCM
58
Perkins Capital Management
Minnesota
$2.13M -$32.3K -825 -2%
Goldman Sachs
59
Goldman Sachs
New York
$2.12M -$371K -9,480 -16%
Prudential Financial
60
Prudential Financial
New Jersey
$2.05M +$49.7K +1,270 +3%
GI
61
GAMCO Investors
Connecticut
$2.04M -$192K -4,900 -9%
IIM
62
Ironwood Investment Management
Massachusetts
$1.89M -$31.9K -815 -2%
CS
63
Credit Suisse
Switzerland
$1.86M +$177K +4,520 +12%
UBS AM
64
UBS AM
Illinois
$1.79M +$125K +3,184 +8%
BA
65
Bridgewater Associates
Connecticut
$1.78M +$1.63M +41,653 New
FQ
66
First Quadrant
California
$1.73M -$168K -4,300 -10%
Barclays
67
Barclays
United Kingdom
$1.68M -$1.16M -29,582 -43%
Citigroup
68
Citigroup
New York
$1.68M +$972K +24,867 +172%
D.E. Shaw & Co
69
D.E. Shaw & Co
New York
$1.6M -$1M -25,584 -41%
Skandinaviska Enskilda Banken (SEB)
70
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.58M +$41.7K +1,067 +3%
US Bancorp
71
US Bancorp
Minnesota
$1.49M +$5.75K +147 +0.4%
FG
72
Formula Growth
Quebec, Canada
$1.48M
Canada Life
73
Canada Life
Manitoba, Canada
$1.45M -$25K -640 -2%
Thrivent Financial for Lutherans
74
Thrivent Financial for Lutherans
Minnesota
$1.4M -$7.2K -184 -0.6%
Squarepoint
75
Squarepoint
New York
$1.4M +$309K +7,891 +32%

CSII Hedge Fund Activity: Q2 2021 in Review

173 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q2 2021, worth a combined $1.61B — up 12% from $1.44B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of CSII and 18 opened new positions — a net loss of 1 holder — while 63 trimmed existing stakes and 67 added.

The largest buyer was JP Morgan Chase, adding an estimated $13.4M. The largest seller was Frontier Capital Management, exiting entirely with an estimated $7.43M sold.

  • 173 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q2 2021, down from 174 in Q1 2021.
  • Funds reported $1.61B of Cardiovascular Systems, Inc. stock for Q2 2021, up 12% quarter-over-quarter.
  • 18 funds opened new Cardiovascular Systems, Inc. positions in Q2 2021 and 19 closed out, a net change of -1 holder.
  • The largest Cardiovascular Systems, Inc. buyer in Q2 2021 was JP Morgan Chase, an estimated $13.4M added.
  • The largest Cardiovascular Systems, Inc. seller in Q2 2021 was Frontier Capital Management, an estimated $7.43M sold.

Based on aggregated 13F filings for Q2 2021.